NONQUALIFIED STOCK OPTION AGREEMENT FOR QUIKBYTE SOFTWARE, INC. AgreementNonqualified Stock Option Agreement • September 21st, 2009 • Quikbyte Software Inc • Blank checks • Delaware
ESCROW AGREEMENTEscrow Agreement • September 21st, 2009 • Quikbyte Software Inc • Blank checks • Delaware
The Escrow Agent may assume that any Claim Notice, Response Notice or other notice of any kind required to be delivered to the Escrow Agent and any other Person has been received by such other Person on the date it has been received by the Escrow Agent, but the Escrow Agent need not inquire into or verify such receipt.
STOCK PURCHASE AGREEMENTStock Purchase Agreement • September 21st, 2009 • Quikbyte Software Inc • Blank checks • California
This Stock Purchase Agreement is entered into as of June 10, 2009 (this “Agreement”), among Sorrento Therapeutics, Inc., a California corporation (the “Company”), and OPKO Health, Inc. (“Buyer”).
FIRST AMENDMENT TO LEASELease • September 21st, 2009 • Quikbyte Software Inc • Blank checks
THIS FIRST AMENDMENT TO LEASE (“First Amendment”) is made and entered into as of the 18th day of August, 2009, by and between SUNTREE GARDEN, LLC (“Landlord”) and SORRENTO THERAPEUTICS, INC., a California corporation (“Tenant”).
PATENT ASSIGNMENT AGREEMENTPatent Assignment Agreement • September 21st, 2009 • Quikbyte Software Inc • Blank checks • California
This Patent Assignment Agreement (“Agreement”) is made as of June 10, 2009 by Henry H. Ji, an individual (“Assignor”), to Sorrento Therapeutics, Inc., a California corporation having a place of business at 10054 Mesa Ridge Court, Suite 122, San Diego, CA 92121 (“Assignee”).
SORRENTO THERAPEUTICS, INC. STOCKHOLDER VOTING AGREEMENTStockholder Voting Agreement • September 21st, 2009 • Quikbyte Software Inc • Blank checks • Delaware
This STOCKHOLDER VOTING AGREEMENT, dated as of July 14, 2009 (this “Agreement”), is by and among QuikByte Software, Inc., a Colorado corporation (“Parent”), and the stockholder of Sorrento Therapeutics, Inc., a Delaware corporation (“Sorrento”), set forth on the signature page hereto (“Stockholder”). Capitalized terms used herein and not otherwise defined shall have the respective meanings ascribed thereto in the Merger Agreement (as defined below).
STOCK PURCHASE AGREEMENTStock Purchase Agreement • September 21st, 2009 • Quikbyte Software Inc • Blank checks
THIS STOCK PURCHASE AGREEMENT (this “Agreement”), dated as of September 18, 2009, is made by and between QuikByte Software, Inc., a Colorado corporation (the “Company”), and each of the Investors listed on Exhibit A hereto (each, an “Investor” and collectively, the “Investors”).
LIMITED LICENSE AGREEMENTLimited License Agreement • September 21st, 2009 • Quikbyte Software Inc • Blank checks • California
This Limited License Agreement (this “Agreement”), effective the 10th day of June, 2009 (the “Effective Date”), is by and between Sorrento Therapeutics, Inc., a California corporation (“STI”), having its principal place of business at San Diego, California, U.S.A. and OPKO Health, Inc., a Delaware corporation (“OPKO”), having its principal place of business at Miami, Florida, U.S.A. As used herein, each of OPKO and STI are referred to individually as a “Party” and collectively as the “Parties”.
LOCK-UP AGREEMENTLock-Up Agreement • September 21st, 2009 • Quikbyte Software Inc • Blank checks
The undersigned, a holder of shares of Sorrento Therapeutics, Inc., a Delaware corporation (“Sorrento”), and/or QuikByte Software, Inc., a Colorado corporation (together with its successors, “Parent”), will hold shares of common stock, $0.0001 par value, of Parent (“Parent Shares”) after the transactions contemplated by that certain Merger Agreement, dated as of July 14, 2009 by and among Sorrento, Parent, Sorrento Merger Corp., Inc., a Delaware corporation, Stephen Zaniboni, an individual as the Stockholders’ Agent thereunder, and Glenn Halpryn, an individual as Parent Representative thereunder, as amended (the “Merger Agreement”). For good and valuable consideration, the undersigned hereby irrevocably agrees that following the closing of the merger contemplated under the Merger Agreement (the “Merger”), the undersigned will not, directly or indirectly, (1) offer for sale, sell, pledge or otherwise dispose of (or enter into any transaction or device that is designed to, or could be ex
